An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
X. Chi, X. Zhang, S. Pan…·W. Yang
This paper develops a biparatopic nanobody with broad neutralization against multiple SARS-CoV-2 variants, including Omicron, showing strong affinity and activity.